2,044 events on record Subscribe September 10, 2026
Standing Record home The Standing Record A non-partisan record of US democratic norms —
and the events that erode them.

EPA ended decades-long practice of monetizing air-pollution health benefits in Clean Air Act rulemaking analysis

On January 15, 2026, the EPA under Administrator Lee Zeldin finalized a rule revising New Source Performance Standards for stationary combustion and gas turbines that, for the first time, said the agency would no longer assign a dollar value to the health benefits of reduced fine particulate matter (PM2.5) and ozone pollution in its regulatory cost-benefit analysis, while continuing to fully count compliance costs to industry. The EPA cited general modeling uncertainty but did not cite new peer-reviewed science justifying a break from the quantification methods it and prior Republican administrations had used for decades. Senate Democrats led by Sen. Sheldon Whitehouse opened an investigation into the change in February 2026, and the agency applied the same non-monetization approach in at least one later 2026 rulemaking.

Part of: EPA's Non-Monetization Cost-Benefit Methodology

Jurisdiction
Federal
Location
Washington, D.C.

Abuses documented

Actors

On January 15, 2026, the U.S. Environmental Protection Agency under Administrator Lee Zeldin published a final rule revising New Source Performance Standards for stationary combustion and gas turbines. Buried in the rule's cost-benefit analysis, the EPA announced that it would no longer assign a monetary value to the health benefits of reducing fine particulate matter (PM2.5) and ozone -- two of the most well-studied and damaging air pollutants -- citing "uncertainties" in exposure modeling and mortality valuation. The rule states the agency will continue to quantify emissions reductions but will not monetize the resulting health benefits "until the Agency is confident enough in the modeling to properly monetize those impacts." EPA did not cite new peer-reviewed studies establishing greater uncertainty than the epidemiological and economic methods it had relied on for decades, including under prior Republican administrations, to estimate the monetized value of avoided deaths, hospitalizations, and illness from air pollution.

The shift is one-sided: the EPA continued to fully quantify and monetize compliance costs to industry in the same analysis, while assigning zero value to the pollution-reduction health benefits on the other side of the ledger. The Clean Air Act and longstanding executive-branch cost-benefit review practice (Executive Order 12866) require agencies to weigh both sides when justifying a rule. A former EPA attorney, reacting to a related 2026 EPA rollback that used the same one-sided accounting, said: "If you only look at one side of the ledger, it's always going to come out one way."

Updates

2026-02-17 — Senate Democrats opened investigation into EPA's benefit-accounting shift

Senate Environment and Public Works Committee Ranking Member Sheldon Whitehouse, joined by 31 other Senate Democrats, sent EPA Administrator Zeldin a letter demanding documents and information -- including draft and final analyses, cost-benefit modeling, scientific justifications, and communications with industry -- related to the agency's decision to stop counting health benefits in Clean Air Act cost-benefit analysis, with a response deadline of February 24, 2026. The senators wrote that the change could sacrifice more than $40 billion in public health gains to save industry an estimated $590 million in compliance costs. [3]

2026-03-16 — Environmental groups sued EPA over the rule in the D.C. Circuit

Sierra Club, the American Lung Association, Clean Wisconsin, Citizens for Pennsylvania's Future, Environmental Defense Fund, and the Natural Resources Defense Council filed a petition for review in the U.S. Court of Appeals for the D.C. Circuit challenging the January 15 rule, arguing EPA "abruptly abandoned its longstanding practice of evaluating the quantified health benefits" of reduced air pollution without notice-and-comment. [5]

Why we recorded this

Federal rulemaking is supposed to weigh both costs and benefits so the public interest, not just industry expense, shapes regulation. The EPA abandoned that balance for fine particulate matter and ozone, continuing to fully count industry compliance costs while treating the resulting health benefits as too uncertain to assign any dollar value to -- without citing new science to justify reversing decades of its own practice, including under prior Republican administrations. This one-sided accounting lets an agency created to protect public health quietly narrow its own mandate through analytical methodology, favoring polluters' costs over documented, life-saving air-quality improvements, without going through a public, statutory process to change what the Clean Air Act requires it to weigh.

Sources

  1. New Source Performance Standards Review for Stationary Combustion Turbines and Stationary Gas Turbines — Federal Register primary accessed August 8, 2026
  2. Trump's EPA is using this sneaky tactic to let nasty industries foul our air — Mother Jones / Slate (Climate Desk) secondary accessed August 8, 2026
  3. Whitehouse Leads Senate Democrats' Investigation into EPA's Decision to Disregard Health Impacts in Air Pollution Standards — U.S. Senate Committee on Environment and Public Works (Minority) primary accessed August 8, 2026
  4. Without Weighing Costs to Public Health, EPA Rolls Back Air Pollution Standards for Coal Plants — Inside Climate News investigative accessed August 8, 2026
  5. EDF, Allies Sue Trump EPA over Weakened Limits on Smog-Forming Pollution from Gas-Burning Power Plants — Environmental Defense Fund primary accessed August 9, 2026

See also